Friday, June 19, 2026
🇺🇸 FDA

pharma · Acute Myeloid Leukemia · Breast Cancer

First People's Hospital

The First People's Hospital of Lianyungang

First People's Hospital clinical programs — 1136 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
SAN DIEGO, CA, CN
Programs
1136
Drugs
626
Patents
123
All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

First People's Hospital projects

1,136 ClinicalTrials.gov programs sponsored by First People's Hospital.

First People's Hospital has 1,136 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,136 programs

Clinical programs

Page 3 of 24

  1. Venetoclax in combination with fludarabine and melphalan

    The First People's Hospital of Lianyungang

    Venentoclax

    phase 3 small molecule active

    1 trial

  2. Visilizumab

    The First People's Hospital of Lianyungang

    Immunotherapy

    phase 3 small molecule active

    1 trial

  3. Ypeginterferon alfa-2b

    The First People's Hospital of Lianyungang

    Chronic Hepatitis B

    phase 3 small molecule completed

    3 trials

  4. decitabine

    The First People's Hospital of Lianyungang

    Poor Graft Function

    phase 3 small molecule active

    1 trial

  5. decitabine

    The First People's Hospital of Lianyungang

    Acute Myelocytic Leukemia

    phase 3 small molecule active

    1 trial

  6. didroxyprogesterone

    The First People's Hospital of Lianyungang

    Pregnancy Rate

    phase 3 small molecule active

    1 trial

  7. different degrees of adjustment of the injection interval

    The First People's Hospital of Lianyungang

    Exudative Age-Related Macular Degeneration

    phase 3 small molecule active

    1 trial

  8. donor lymphocyte infusion

    The First People's Hospital of Lianyungang

    Minimal Residual Disease

    phase 3 mab completed

    1 trial

  9. esophagectomy

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 3 other active

    1 trial

  10. metformin

    The First People's Hospital of Lianyungang

    Polycystic Ovary Syndrome

    phase 3 small molecule completed

    1 trial

  11. mycophenolate mofetil 2 g per day

    The First People's Hospital of Lianyungang

    Lymphocytic Myocarditis (Disorder)

    phase 3 small molecule completed

    1 trial

  12. nab-paclitaxel combined with carboplatin

    The First People's Hospital of Lianyungang

    Epithelial Ovarian Carcinoma Stage III

    phase 3 small molecule active

    1 trial

  13. paclitaxel/anthracycline

    The First People's Hospital of Lianyungang

    Primary Breast Cancer

    phase 3 small molecule active

    1 trial

  14. patients undergo cVATS segmentectomy

    The First People's Hospital of Lianyungang

    Non-small Cell Lung Cancer Stage I

    phase 3 other active

    1 trial

  15. probiotics, antibiotics or antidepressants

    The First People's Hospital of Lianyungang

    Irritable Bowel Syndrome

    phase 3 small molecule active

    1 trial

  16. recombinant human erythropoietin

    The First People's Hospital of Lianyungang

    Lymphoma

    phase 3 small molecule active

    1 trial

  17. recombinant human thrombopoietin

    The First People's Hospital of Lianyungang

    Immune Thrombocytopenia

    phase 3 small molecule active

    1 trial

  18. rhTPO

    The First People's Hospital of Lianyungang

    Immune Thrombocytopenia

    phase 3 small molecule active

    1 trial

  19. the Shouhui Tongbian Capsule

    The First People's Hospital of Lianyungang

    OIC

    phase 3 small molecule active

    1 trial

  20. ticagrelor

    The First People's Hospital of Lianyungang

    Coronary Artery Disease

    phase 3 small molecule active

    1 trial

  21. venetoclax

    The First People's Hospital of Lianyungang

    Acute Promyelocytic Leukemia

    phase 3 small molecule active

    1 trial

  22. "Endostar"

    The First People's Hospital of Lianyungang

    Esophageal

    phase 2 small molecule terminated

    1 trial

  23. 0.9% sodium chloride

    The First People's Hospital of Lianyungang

    Kidney Disease, Chronic

    phase 2 small molecule active

    1 trial

  24. 13914704178

    The First People's Hospital of Lianyungang

    Locally Advanced Esophageal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  25. 177Lu-DOTA-EB-FAPI radionuclide therapy

    The First People's Hospital of Lianyungang

    Refractory Solid Tumor

    phase 2 small molecule completed

    1 trial

  26. 18F-92

    The First People's Hospital of Lianyungang

    Alzheimer's Disease

    phase 2 small molecule active

    1 trial

  27. 20170512

    The First People's Hospital of Lianyungang

    Triple-Negative Breast Cancer

    phase 2 small molecule completed

    1 trial

  28. 2021-SR-545

    The First People's Hospital of Lianyungang

    Lymphoma, Large B-Cell, Diffuse

    phase 2 small molecule active

    1 trial

  29. 2023-SR-002

    The First People's Hospital of Lianyungang

    NK-T-Cell Lymphoma, Extranodal

    phase 2 small molecule active

    1 trial

  30. 2024-HS-022

    The First People's Hospital of Lianyungang

    Platinum-sensitive Relapsed Ovarian Cancer

    phase 2 small molecule active

    1 trial

  31. 2025-206

    The First People's Hospital of Lianyungang

    Radiation - Induced Proctitis

    phase 2 small molecule active

    1 trial

  32. 2025-SR-813

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 2 small molecule active

    1 trial

  33. 225Ac-LNC1011

    The First People's Hospital of Lianyungang

    Prostate Cancer

    phase 2 small molecule active

    1 trial

  34. 3D hypoxia-preconditioned UC-MSC group

    The First People's Hospital of Lianyungang

    Severe Aplastic Anemia (SAA)

    phase 2 small molecule active

    1 trial

  35. 68Ga-DOTATATE and 68Ga-FAPI

    The First People's Hospital of Lianyungang

    Tumor Positron-Emission Tomography

    phase 2 small molecule completed

    1 trial

  36. 68Ga-FAP-CHX

    The First People's Hospital of Lianyungang

    Tumor

    phase 2 small molecule active

    1 trial

  37. 68Ga-G21

    The First People's Hospital of Lianyungang

    Prostate Cancer (Adenocarcinoma)

    phase 2 small molecule active

    1 trial

  38. 68Ga-NY104 PET/CT

    The First People's Hospital of Lianyungang

    Clear Cell Renal Cell Carcinoma

    phase 2 small molecule active

    1 trial

  39. AK105 and anlotinib

    The First People's Hospital of Lianyungang

    Cervical Cancer

    phase 2 small molecule active

    1 trial

  40. ASC22

    The First People's Hospital of Lianyungang

    Chronic Hepatitis b

    phase 2 small molecule completed

    1 trial

  41. Abatacept s.c.

    The First People's Hospital of Lianyungang

    Abatacept

    phase 2 small molecule active

    1 trial

  42. Absorbable and moldable skull base support plate

    The First People's Hospital of Lianyungang

    Sellar Tumor

    phase 2 other active

    1 trial

  43. Ad-HGF

    The First People's Hospital of Lianyungang

    Myocardial Infarction

    phase 2 small molecule active

    1 trial

  44. Adebellizumab

    The First People's Hospital of Lianyungang

    Resectable Lung Non-Small Cell Carcinoma

    phase 2 small molecule active

    1 trial

  45. Adebrelimab+Albumin paclitaxel +Cisplatin

    The First People's Hospital of Lianyungang

    Locally Advanced Hypopharyngeal Cancer

    phase 2 small molecule active

    1 trial

  46. All-trans Retinoic Acid in combination with the KPD Regimen

    The First People's Hospital of Lianyungang

    Multiple Myeloma in Relapse

    phase 2 small molecule active

    1 trial

  47. Almonertinib

    The First People's Hospital of Lianyungang

    Non Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  48. Almonertinib

    The First People's Hospital of Lianyungang

    EGFR Positive Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does First People's Hospital have?

1,136 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.